Most biopharmaceuticals use cloud-based infrastructure at some level. But just how “cloudy” is your business? Many companies are in a hybrid state, on a path from traditional on-premise infrastructure to operating fully in the cloud. That journey can feel arduous, and it may seem easier to pause along the way. But a truly cloud-only approach…
AWS and pharma heavyweights join forces on AI-based drug discovery lab
The goal of using artificial intelligence to transform drug discovery and development may not be novel. But a new alliance is unique in both the stature of companies belonging to it and its choice of an innovation model. Big Pharma firms AstraZeneca (LON:AZN), Merck KGaA (ETR: MRK), Pfizer (NYSE:PFE) and Teva (NYSE:TEVA) will partner with Amazon…